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Pedicellarial toxin, partially purified from the sea urchin To.uopneustes pileolus, dose-dependently and time-dependently caused histamine release 
from rat perttoneal mast cells. Pedicellarial toxin induced a rapid mmal rise m [Ca”], within several seconds which was followed by a further slower 
increase of [Ca”], (second rise). The toxm induced a dose-dependent formation of inositol 1,4.5-triphosphate (IP3) as well as the histamine release 
in mast cells. Furthermore. the toxin stimulated phosphomositide-specific phosphohpase C (PI-PLC) activity in mast cell membranes. 2-Nitro-4- 
carboxyphenyl-N,N-diphenylcarbamate (NCDC). a PLC mhibitor, inhibited the activation of PI-PCL induced by pedicellarial toxin. Cholera toxin 
inhibited pedicellarial toxin-induced histamine release. whereas pretreatment of pertussis toxin failed to inhibit it. These results suggest that 
pedicellarial toxin from 7: pileolus activates PI-PCL and the stimulation of PI turnover may lead to the release of IP3 into the cytoplasm, resultmg 
in histamine release from rat mast cells. 
Pedicellarial toxin, Histamine release; Mast cell: IP3; PI-PLC 
1. INTRODUCTION 
The globiferous pedicellariae of the toxopneustid sea 
urchins, Toxopneustes pileolus and Tripneustes gratilla 
contain toxic substances [l-5]. The pharmacological 
properties of the pedicellarial venom of the sea urchin 
7: pileolus have been studied in some tissues [6,7]. We 
have previously demonstrated that an extract from the 
pedicellariae of l? pileolus caused a release of histamine 
from rat peritoneal mast cells [8]. More recently, we 
reported also that a toxic substance (P-II fraction), frac- 
tionated from the pedicellariae of 7: pileolus caused 
histamine release from mast cells and the release ap- 
peared to be sensitive to the glycolytic pathway [9]. 
mobilization of intracellular calcium and enhancement 
of the hydrolysis of phosphoinositide [ 131. 
The present study was undertaken to evaluate the 
mode of action of pedicellarial toxin, partially purified 
from 7: pileolus, on rat peritoneal mast cells and 
in particular, to examine the involvement of phospho- 
lipase C activation in the secretory process. 
2. MATERIALS AND METHODS 
2.1. Partial purification of pedicellarlal toxin 
Pedicellarial toxin was partially purified from the globiferous 
pedicellariae of the sea urchin 7: pdeolus as reported previously [14]. 
Briefly, the crude extract from the pedicellariae was subjected to the 
gel filtration of a Sephadex G-200 column (2.6 x 65 cm) equilibrated 
with 0.15 M NaCl solution. The active fraction (P-II fraction) was 
dissolved m 0.02 M Tris-HCl buffer (pH 7.4) containing 0.4 M NaCl 
and applied on a concanavalm A-Sepharose column (1 x IO cm) eqml- 
ibrated with the same buffer. The sample was eluted, and unretained 
protein fractions were obtained as Pre-Con A fraction In the present 
experiments, Pre-Con A fraction was pooled and further fractionated 
m a column (2.6 x 60 cm) of Sephadex G-75 using 0.15 M NaCl 
solution. The active fraction was recovered into second protein peak 
(F-II fraction). The biological activity (U) of F-II fraction was bioas- 
sayed for the isometric contraction of longitudmal muscle of the iso- 
lated guinea-pig ileum in an oxygenized Krebs-Ringer bicarbonate at 
37°C by the modified method of Kimura et al. [14] Total protein of 
F-II fraction was 10.26 mg and its specific activity was 9,000 Ulmg 
protein and this fraction was used as pedicellarial toxin in the present 
experiment. 
The activation of mast cells by cross-linking of the 
high affinity IgE-Fc receptor (FcERI) induces the secre- 
tion of a variety of performed biological active sub- 
stances that mediate allergic and inflammatory 
responses [lo]. The biochemical events involved in 
the triggering of histamine release suggested that the 
bridging of IgE receptors on mast cells results in activa- 
tion of various membrane associated enzymes [11,12], 
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2.2. Preparation of mast cells 
Rat peritoneal mast cells were obtained from male Wistar rats 
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(200-~300 g) [I51 and mast cells were purified usmg a method of 
Nemeth and Rohhch [I61 
The mast cell suspenstons in Tyrode HEPES solution (pH 7 4) were 
mcubated in duphcate at 37°C for 5 mm before the additton of an 
approprtate concentratton of vartous agents. TyrodeeHEPES solution 
contamed 124 mM NaCI, 4 0 mM KCI, I 0 mM CaCl?, IO mM 
NaHCO,. 5.6 mM glucose, 0 64 mM NaH?PO,. 0 5 mM MgSO,. 5 0 
mM N-2-hydroxyethylptperazme-h”-2-ethane sulfomc acid (HEPES). 
50 mg of bovine serum albumm (BSA) per hter. BSA was omitted from 
the solution m experiments on histamme release. At intervals. the 
reactton was stopped by the addttion of I mM TrisEDTA buffer. The 
Trts EDTA buffer contamed 25 mM Trts. 120 mM NaCl, 5 mM KCI. 
1 mM EDTA and 20 mg human serum albumin per hter. Then. the 
cells were separated from the released histamme by centrtfugation at 
1300 x i: for IO mm at 4°C. Restdual htstamme remammg m the cells 
was released by dtstruptmg the cells wtth 100% trichlortc actd (TCA). 
and centrifugatton at 1500 x g for I5 min at 4°C. Htstamme content 
was determmed fluorometrically [I 71. The amount of histamine re- 
leased was calculated as percentage of the total htstamme present m 
the control suspenston. 
Fluoresense was recorded usmg a tluorimeter (model 650-40 Fluo- 
rescence 100. Hitacht) utth a temperature-controlled cuvette and a 
magnettcally drtven sttrrer. Purtfied ma,t cells (1 x 10” cells/ml) were 
Incubated at 37°C for IO mm with 100 ,uM Qun-YAM 2-[(l-ammo- 
5-methylphenoxy)meth~I]-6-methoxy-8-ammoqu~nol~ne-h7 N.N.N-tetra- 
acettc acid, tetraacetoxymethyl ester in TyrodeeHEPES solution. The 
cell suspension was diluted 1:lO wtth Tyrode-HEPES solution. left to 
stand for 60 mm. and then washed twice wtth complete solution 
Samples of the cell \uspenston (I x IO’ cells/ml) here placed m the 
cuvette descrtbed above, and agents were with a microsyrmge directly 
mto the cuvette. without mterruptmg the recordmg. The cell suspen- 
sion was incubated at 37°C for 5 mm and challenged wtth pedicellartal 
toxm. Fluorescence excitation and emission wavelengths were 339 nm 
and 492 nm, respecttvely. The concentration of mtracellular Ca” was 
calculated by the method of Tsten et al. [IS] 
Measurment of IP3 was carried out usmg a commerctally avatlable 
kit (Amersham) and the manufacturer’s protocol. Briefly. mast cells 
were extracted wtth chloroform/methanol (1.2) on tee for IO mtn. 
Methanol fracttons contammg phosphorylated mositols were lysophil- 
tzed and mixed with bovme adrenal IP3-bmdmg protetns m the pres- 
ence of limiting amount of tracer o-myo-[‘H]inositol l,4,5-tri- 
phosphate The mixtures were centrifuged at 2000 x g for IO min and 
radioacttvtty bound to IP3-bmding protem was measured m a ,& 
scmttlation counter. 
The activity of PI-PLC in rat mast cell membrane fraction was 
measured as descrtbed by Mustelin et al. [l9]. Purified mast cells were 
suspended m Tyrode- HEPES solution. After washmg. mast cells were 
resuspended m 1 ml lys~s buffer contammg 25 mM Tris (pH 7.5). 25 
mM sucrose, 0. I mM EGTA and 5 mM MgCl,. The cells were homog- 
enized by sonication and the samples were centrtfuged at 1000 x R to 
sedtment the nuclei. The post-nuclear supernatant was centrtfuged at 
10.000 x g for 30 mm. The cytosohc fractton was recovered and the 
sedimentable membrane pellet was resuspended in lysis buffer, Protem 
was determined by the method of Bradford [20]. Membrane prepara- 
tton of mast cells was assayed in a final volume of 50 ~1 contaming 
70 mM sodium phosphate (pH 6 8). 40 mM KCI, I mM sodium 
pyrophosphate. 0.65% octylglucostde. 0.4 mM EGTA. 0 8 mM CaCI,. 
aprotinm (10 &ml), leupeptm (IO fig/ml) and 0 2 mM [‘Hlphosphat- 
tdylinosttol-4,5-biphosphate (5pCilml). The mixture was incubated at 
37°C for 15 min and the reaction was stopped by adding 100 ,uI of I % 
bovme serum albumm. followed by 500 ~1 of 10% TCA The precipi- 
60 
tate was removed by centrtfugatton and the radioacttvtty present m 0 5 
ml of the supernatant was determmed. The counts from a control 
mcubation with no enzyme (buffer only. 284 ? 13 cpm) was subtracted 
from all values 
3. RESULTS 
Pedicellarial toxin induced histamine release from rat 
peritoneal mast cells in a dose-dependent manner (Fig. 
1). The toxin-induced histamine release was evoked 
with the concentrations higher than 20 ,&ml and 
reached a maximum at a concentration of 1000 ,ug/ml. 
At 20, 80 and 400 ,uglml the histamine release induced 
by pedicellarial toxin at the incubation for 1.5 min was 
6 + l%, 14 ? 3% and 29 2 4%. respectively. The toxin, 
at its optimal concentration of 400 pug/ml, produced a 
time-dependent release of histamine from the mast cells. 
The histamine release was essentially complete within 
15 min (data not shown). 
Purified mast cells were challenged with 80 ,ug/ml of 
pedicellarial toxin. The toxin induced a rapid increase 
in [Ca”], within several seconds and the maximal in- 
crease was about 170 nM (data not shown). As shown 
in Fig. 2, at 20, 40, 80, 200 and 400 pug/ml, the initial 
increase in [Ca”], induced by pedicellarial toxin was 
40&4. 69&4, 168+4. 1732~5 and 186+7 nM, re- 
spectively. 
There are several mechanisms involved in the regula- 
tion of intracellular Ca”. some which function to con- 
trol Ca” entry into the cell through the plasma mem- 
brane. and others which release Ca’+ from an intracellu- 
lar pool by the second messenger IP3 [21]. Therefore, 
we examined the effect of pedicellarial toxin on IP3 
so r 
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Ftg. 1. Dose-response curve for the histamme release from mast cells 
induced by pedicellartal toxin. The mast cells (5 x IO’ cells/ml) were 
Incubated wtth pedicellarial toxm for IO mm Spontaneous histamme 
release from mast cells was 5.3 f 0 3%, and this value was subtracted 
from each expertmental value. Each pomt represents the mean of 5 
ewpertments and vertical bars indtcate S.E.M. 
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Fig. 2. Effect of pedicellartal toxin on [Ca”‘], increase in mast cells. The 
mast cells (1 x IO5 cells/ml) were incubated at 37°C for 5 mm and 
challenged with various concentratrons of pedicellarial toxm. The m- 
crease m [Ca”], in the cells was measured as descrrbed m sectron 2. 
Each point represents the mean of 5 experiments and vertical bars 
mdicate S.E.M. 
generation. Fig. 3 shows kinetics of IP3 generation in- 
duced by pedicellarial toxin (20400 puglml). The toxin 
at a concentration of 40 pug/ml induced a rapid increase 
in IP3 generation in mast cells, the maximal value was 
4.9 & 0.4 pmol/107 cells after 20 s. The levels decreased 
to 0.5 + 0.02 pmol/107 cells after 50 s. At 20, 80, and 400 
pug/ml, the toxin-induced IP3 generation at 20 s was 
1.7 ? 0.6, 5.6 & 0.7 and 6.0 + 0.9 pmoll10’ cells, respec- 
tively. 
The above results suggest that pedicellarial toxin-in- 
duced generation of IP3 is due to a mechanism which 
mediates PI-PLC activation in mast cells. Thus, we ex- 
amined the effect of pedicellarial toxin on the activity 
of PI-PLC in the membrane fraction (Fig. 4). At 20, 80 
and 200 ,&ml, the activity of PI-PLC induced by the 
toxin was 39 2 4, 73 + 6 and 75 + 6 pmoVIP3, respec- 
tively. Moreover, the observed effect of the toxin could 
result from either direct or indirect activation of PI- 
PLC. To investigate this point, we made use of 2-nitro- 
4-carboxyphenyl-N,N-diphenyl-carbamate (NCDC), 
an inhibitor of phospholipase C. At 100 PM, NCDC 
produced half-maximum inhibition of PI-PLC activa- 
tion induced by pedicellarial toxin (Fig. 4). 
Pertussis toxin (PT) and cholera toxin (CT) have been 
found to inhibit phospholipase C activation [22-241. We 
examined whether PT or CT inhibits histamine release 
from mast cells induced by pedicellarial toxin. The cells 
were preincubated with PT or CT at a concentration of 
10 pug/ml at 37°C for 3 h, and then PT- and CT-treated 
cells were incubated with the toxin (400 fig/ml) for 15 
min. PT failed to inhibit the toxin-induced histamine 
release, whereas CT inhibited the histamine release to 
68% of control (data not shown). 
4. DISCUSSION 
The present study is the first report that pedicellarial 
toxin from I: pileoZus causes the activation of PI-PLC 
and generates IP3 in dose-dependent manner, and then 
induces histamine release from rat mast cells. 
Mast cells release inflammatory mediators through 
the reaction of cell-bound IgE antibodies with multiva- 
lent antigen [lo] and through various IgE-independent 
stimuli [25]. The cellular events that take place following 
stimulation of mast cells include breakdown of inositol 
phospholipids, transient increase of the intracellular 
free Ca” concentration ([Ca’+ll, generation of ara- 
chidonic acid, and increase in cyclic nucleotides [26]. In 
the present study, pedicellarial toxin induced a rapid 
initial increase in [Ca”], within several seconds. It has 
been suggested that the initial rise in [Cal+],, due to Cal+ 
mobilization, correlates with the histamine release pro- 
moted by the various secretagogues [27]. Thus, the re- 
sponse to the toxin appears to be due to the release of 
Ca”+ from internal stores in mast cells. 
Rapid increase in the generation of IP3 was observed 
with 20 s after addition of pedicellarial toxin. The gener- 
ation of IP3 and the rise in [Ca”], in mast cells activated 
by the toxin showed a close correlation. Recent evidence 
demonstrates that IP3 stimulates Ca” release from the 
intracellular stores in mast cells [28]. 
It seems that the inositol phospholipid cascade re- 
quires to activate Ca” release. Therefore, we examined 
the activation of PI-PLC by pedicellarial toxin in mast 
cell membrane fraction. The toxin produced the activa- 
tion of PI-PLC at the same concentration range similar 
Time (set) 
Fig. 3. Kmetics of pedtcellartal toxin-induced generation of IP3. The 
mast cells (1 x 10 cells/ml) were incubated at 37°C for 5 min and 
challenged with various concentrations of pedicellarial toxm. IP3 was 
analyzed as described m section 2. The generation of IP3 in control 
mast cells was 0.3 + 0.05 pmol/lO cells and this value was subtracted 
from experimental values. Each point represents the mean of 5 exper- 
iments and vertical bar indtcate S.E M. 0, 20,&ml: l , 80,~uglml; A. 
400 pglml. 
61 
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PI-PLC activity (pmol/IP3) 
Fig. 4. Effect of pedicellarial toxin on the enzymatic activity of PI-PLC 
and Inhibition of PI-PLC activity by NCDC. The cells ( I x 10 cells/ml) 
were disrupted by somcation and pellet and cytosol fractions were 
assessed for PLC activity by the procedures described m section 2. 
Absctssa represents pmoles IP3 formed by hydrolysis of [‘HI- 
phosphatidylinositol 4.5-btsphosphate. Each point represents the 
mean of 5 experiments and vertival bars Indicate SE M 
to that for histamine release. Furthermore. the stimula- 
tory effect of the toxin on the activity of PI-PLC was 
inhibited by NCDC. We previously demonstrated that 
NCDC inhibited histamine release, the initial rise in 
[Ca”], and the generation of IP3 in mast cells activated 
by anti-IgE [29]. 
CT caused the inhibition of the toxin-induced hista- 
mine release, whereas PT treatment failed to inhibit the 
toxin-induced histamine release from mast cells. The 
histamine release induced by the toxin could not be 
caused by cell surface-receptor interaction. since it 
might be caused by a direct interaction of the CT-acti- 
vated GTP-binding proteins with PLC. In some cells, 
CT was shown to inhibit receptor-mediated activation 
of phospholipase C [30,31]. Our data suggest that in rat 
mast cells CT might activate GTP-binding proteins, 
which are involved in regulation of pedicellarial toxin- 
induced activation of phospholipase C. 
The pedicellarial toxin showed at least three protein 
bands (mol. wt. = 17-30 kDa) by SDS-polyacrylamide 
gel electrophoresis. We have currently isolated a protein 
component in the toxin by high performance liquid 
chromatography and it showed a molecular weight of 
IS kDa (unpublished observation). The characteriza- 
tion of the 18 kDa component is under investigation. 
From these results, we suggest that pedicellarial toxin 
activates PI-PLC and stimulation of PI turnover may 
lead to the release of IP3 into the cytoplasm, and then 
IP3 may trigger mobilization of intracellular Ca’+, re- 
sulting in histamine release from rat mast cells. PI-PLC 
activation may be a prerequisite for histamine release 
from rat mast cells induced by pedicellarial toxin. 
Pedicellarial toxin and purified pedicellarial toxin from 
i? pileohs should be useful in studies on the functional 
connection between the G-protein involved and PI-PLC 
that regulates histamine release from mast cells. 
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